00000000cam 2200000zi 4500
0019.963231
003CaOODSP
00520260722080112
006m     o  d f      
007cr mn ||||||||
008260601e202603##onc     o    f000 0 eng d
020 |a9780662346166
040 |aCaOODSP|beng|erda|cCaOODSP
0410 |aeng|beng|bfre
043 |an-cn---
0861 |aH21-316/2026E-PDF
24500|a2025/26 inhalable cannabis concentrates survey : |bfinal report / |cprepared for Health Canada.
24617|a2025/2026 inhalable cannabis concentrates survey : |bfinals report
264 1|aOttawa, Ontario : |bHealth Canada, |cMarch 2026.
264 4|c©2026
300 |a1 online resource (178 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |a"Unclassified."
500 |a"Supplier name: Advanis Inc."
500 |a"Contract number: CW2424577."
500 |a"Registration number: POR 45-25."
500 |aIssued also in French under title: Enquête sur les concentrés de cannabis inhalables de 2025-2026 : rapport final.
520 |a"The primary objective of this research is to collect information on the use of inhalable cannabis concentrates among cannabis consumers in Canada"--Research objectives, page 9.
546 |aText in English, Appendix B (Questionnaire) in French.
650 0|aCannabis|zCanada|xPublic opinion.
650 0|aMarijuana industry|zCanada|xPublic opinion.
650 0|aConsumers|zCanada|xAttitudes|xResearch.
650 0|aPublic opinion|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
7102 |aAdvanis (Firm), |econsultant.
77508|tEnquête sur les concentrés de cannabis inhalables de 2025-2026 : |w(CaOODSP)9.963230
85640|qPDF|s1.77 MB|uhttps://publications.gc.ca/collections/collection_2026/sc-hc/H21-316-2026-eng.pdf|zFinal report
8564 |qHTML|sN/A|uhttps://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2026/045-25-e/045-25-report.htm|zFinal report
8564 |qHTML|sN/A|uhttps://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2026/045-25-e/index.html?nodisclaimer=1|zComplete data set